Robert Kirkman

2015 - Oncothyreon

In 2015, Robert Kirkman earned a total compensation of $2.3M as Former President, Chief Executive Officer and Director at Oncothyreon, a 121% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$116,493
Option Awards$1,687,500
Salary$448,050
Other$8,442
Total$2,260,485

Kirkman received $1.7M in option awards, accounting for 75% of the total pay in 2015.

Kirkman also received $116.5K in non-equity incentive plan, $448.1K in salary and $8.4K in other compensation.

Rankings

In 2015, Robert Kirkman's compensation ranked 4,257th out of 13,638 executives tracked by ExecPay. In other words, Kirkman earned more than 68.8% of executives.

ClassificationRankingPercentile
All
4,257
out of 13,638
69th
Division
Services
731
out of 2,167
66th
Major group
Engineering, Accounting, Research, Management, And Related Services
39
out of 197
80th
Industry group
Research, Development, And Testing Services
12
out of 65
82nd
Industry
Commercial Physical and Biological Research
12
out of 53
77th
Source: SEC filing on April 26, 2017.

Kirkman's colleagues

We found four more compensation records of executives who worked with Robert Kirkman at Oncothyreon in 2015.

2015

Diana Hausman

Oncothyreon

Chief Medical Officer

2015

Scott Peterson

Oncothyreon

Chief Scientific Officer

2015

Gary Christianson

Oncothyreon

Chief Operating Officer

2015

Julia Eastland

Oncothyreon

Chief Financial Officer

In-depth

You may also like